Jeżeli nie znalazłeś poszukiwanej książki, skontaktuj się z nami wypełniając formularz kontaktowy.

Ta strona używa plików cookies, by ułatwić korzystanie z serwisu. Mogą Państwo określić warunki przechowywania lub dostępu do plików cookies w swojej przeglądarce zgodnie z polityką prywatności.

Wydawcy

Literatura do programów

Informacje szczegółowe o książce

Production of Recombinant Proteins: Novel Microbial and Eukaryotic Expression Systems - ISBN 9783527310364

Production of Recombinant Proteins: Novel Microbial and Eukaryotic Expression Systems

ISBN 9783527310364

Autor: Gerd Gellissen

Wydawca: Wiley

Dostępność: 3-6 tygodni

Cena: 1 085,70 zł

Przed złożeniem zamówienia prosimy o kontakt mailowy celem potwierdzenia ceny.


ISBN13:      

9783527310364

ISBN10:      

3527310363

Autor:      

Gerd Gellissen

Oprawa:      

Hardback

Rok Wydania:      

2004-12-10

Ilość stron:      

429

Wymiary:      

251x180

Tematy:      

PN

While the choices of microbial and eukaryotic expression systems for production of recombinant proteins are many, most researchers in academic and industrial settings do not have ready access to pertinent biological and technical information since it is normally scattered throughout the scientific literature. This book closes the gap by providing information on the general biology of the host organism, a description of the expression platform, a methodological section – with strains, genetic elements, vectors and special methods, where applicable – as well as examples of proteins expressed with the respective platform. The systems thus described are well balanced by the inclusion of three prokaryotes (two Gram–negatives and one Gram–positive), four yeasts, two filamentous fungi and two higher eukaryotic cell systems – mammalian and plant cells. Throughout, the book provides valuable practical and theoretical information on the criteria and schemes for selecting the appropriate expression platform, the possibility and practicality of a universal expression vector, and on comparative industrial–scale fermentation, with the production of a recombinant Hepatitis B B vaccine chosen as a n industrial example.
With a foreword by Herbert P. Schweizer, Colorado State University, USA: "As a whole, this book is a valuable and overdue resource for a varied audience. It is a practical guide for academic and industrial researchers who are confronted with the design of the most suitable expression platform for their favorite protein for technical or pharmaceutical purposes. In addition, the book is also a valuable study resource for professors and students in the fields of applied biology and biotechnology."

Spis treści:
1 Key and Criteria to the Selection of an Expression Platform (Gerd Gellissen, Alexander W.M. Strasser, and Manfred Suckow).
2 Escherichia coli (Josef Altenbuchner and Ralf Mattes).
2.1 Introduction.
2.2 Strains, Genome, and Cultivation.
2.3 Expression Vectors.
2.4 Regulation of Gene Expression.
2.5 Transcription and Translation.
2.6 Protein Production.
2.7 Examples of Products and Processes.
2.8 Conclusions and Future Perspectives.
Appendix.
References.
3 Pseudomonas fluorescens (Lawrence C. Chew,Tom M. Ramseier, Diane M. Retallack, Jane C. Schneider, Charles H. Squires, and Henry W. Talbot).
3.1 Introduction.
3.2 Biology of Pseudomonas fluorescens.
3.3 History and Taxonomy of Pseudomonas fluorescens Strain Biovar I MB101.
3.4 Cultivation.
3.5 Genomics and Functional Genomics of P. fluorescens Strain MB101.
3.6 Core Expression Platform for Heterologous Proteins.
3.7 Production of Heterologous Proteins in P. fluorescens.
3.8 Conclusions.
Appendix.
References.
4 Staphylococcus carnosus and other Gram–positive Bacteria (Roland Freudl).
4.1 Introduction.
4.2 Major Protein Export Routes in Gram–positive Bacteria.
4.3 Extracytosolic Protein Folding.
4.4 The Cell Wall as a Barrier for the Secretion of Heterologous Proteins.
4.5 Degradation of Exported Proteins by Cell–associated and Secreted Proteases.
4.6 Staphylococcus carnosus.
Appendix.
References.
5 Arxula adeninivorans(Erik Böer, Gerd Gellissen, and Gotthard Kunze).
5.1 History of A. adeninivorans Research.
5.2 Physiology and Temperature–dependent Dimorphism.
5.3 Genetics and Molecular Biology.
5.4 Arxula adeninivorans as a Gene Donor.
5.5 The A. adeninivorans–based Platform.
5.6 Conclusions and Perspectives.
Acknowledgments.
Appendix.
References.
6 Hansenula polymorpha (Hyun Ah Kang and Gerd Gellissen).
6.1 History, Phylogenetic Position, Basic Genetics and Biochemi stry of H. polymorpha.
6.2 Characteristics of the H. polymorpha Genome.
6.3 N–linked glycosylation in H. polymorpha.
6.4 The H. polymorpha–based Expression Platform.
6.5 Product and Process Examples.
6.6 Future Directions and Conclusion.
Appendix.
References.
7 Pichia pastoris (Christine Ilgen, Joan Lin–Cereghino, and James M. Cregg).
7.1 Introduction.
7.2 Construction of Expression Strains.
7.3 Post–translational Modification of Secreted Proteins.
7.4 Conclusions.
Acknowledgments.
Appendix.
References.
8 Yarrowia lipolytica (Catherine Madzak, Jean–Marc Nicaud, and Claude Gaillardin).
8.1 History, Phylogenetic Position, Basic Genetics, and Biochemistry.
8.2 Characteristics of the Y. lipolytica Genome.
8.3 Description of the Expression Platform.
8.4 Examples.
8.5 Transformation Methods.
8.6 Conclusions and Future Trends.
Acknowledgments.
Appendix.
References.
9 Aspergillus sojae (Margreet Heerikhuisen, Cees van den Hondel, and Peter Punt).
9.1 Introduction.
9.2 Taxonomy.
9.3 The Expression Platform.
9.4 Aspergillus sojae as a Cell Factory for Foreign Proteins.
9.5 Strain Development.
9.6 Outlook.
Acknowledgments.
Appendix.
References.
10 Sordaria macrospora (Ulrich Kück and Stefanie Pöggeler).
10.1 Introduction.
10.2 General Biology.
10.3 Morphological Characterization, Molecular Phylogeny and Life Cycle of Sordaria macrospora.
10.4 Generation of Sterile Mutants as Host Strains.
10.5 S. macrospora as a Safe Host for Heterologous Gene Expression.
10.6 Molecular Genetic Techniques Developed for S. macrospora.
10.7 Isolation and Characterization of Strong Promoter Sequences from S. macrospora.
10.8 Construction of Vectors for Efficient Gene Expressi on in S. macrospora.
10.9 Successful Expression of the Recombinant EGFP Reporter Gene in S. macrospora.
10.10 Conclusions.
Acknowledgments.
Appendix.
References.
11 Mammalian Cells(Volker Sandig, Thomas Rose, Karsten Winkler, and Rene Brecht).
11.1 Why Use Mammalian Cells for Heterologous Gene Expression?
11.2 Mammalian Cell Lines for Protein Production.
11.3 Mammalian Expression Systems.
11.4 Mammalian Cell–based Fermentation Processes.
11.5 Conclusions.
Acknowledgments.
Appendix.
References.
12 Plant Cells (Rainer Fischer, Richard M Twyman, Jürgen Drossard, Stephan Hellwig and Stefan Schillberg).
12.1 General Biology of Plant Cells.
12.2 Description of the Expression Platform.
12.3 Examples of Recombinant Proteins Produced in Plant Cell Suspension Cultures.
12.4 Methodology Using Model Tobacco Cell Suspension Lines to Produce Recombinant Antibodies.
12.5 Conclusions.
Appendix.
References.
13 Wide–Range Integrative Expression Vectors for Fungi, based on Ribosomal DNA Elements (Jens Klabunde, Gotthard Kunze, Gerd Gellissen, and Cornelis P. Hollenberg).
13.1 Why is a Wide–range Expression Vector Needed?
13.2 Which Elements are Essential for a Wide–range Expression Vector?
13.3 Structure of the Ribosomal DNA and its Utility as an Integration Target.
13.4 Transformation Based on rDNA Integration.
13.5 rDNA Integration as a Tool for Targeting Multiple Expression Cassettes.
13.6 Conclusions and Perspectives.
Acknowledgments.
References.
14 Comparative Fermentation (Stephan Hellwig, Christoph Stöckmann, Gerd Gellissen, and Jochen Büchs).
14.1 Introduction.
14.2 Escherichia coli.
14.3 Staphylococcus carnosus.
14.4 Arxula adeninivorans.
14.5 Hansenula polymorpha.
14.6 Sordaria macrospora.
Appendix.
A14.1 Escherichia coli Media.

Koszyk

Książek w koszyku: 0 szt.

Wartość zakupów: 0,00 zł

ebooks
covid

Kontakt

Gambit
Centrum Oprogramowania
i Szkoleń Sp. z o.o.

Al. Pokoju 29b/22-24

31-564 Kraków


Siedziba Księgarni

ul. Kordylewskiego 1

31-542 Kraków

+48 12 410 5991

+48 12 410 5987

+48 12 410 5989

Zobacz na mapie google

Wyślij e-mail

Subskrypcje

Administratorem danych osobowych jest firma Gambit COiS Sp. z o.o. Na podany adres będzie wysyłany wyłącznie biuletyn informacyjny.

Autoryzacja płatności

PayU

Informacje na temat autoryzacji płatności poprzez PayU.

PayU banki

© Copyright 2012: GAMBIT COiS Sp. z o.o. Wszelkie prawa zastrzeżone.

Projekt i wykonanie: Alchemia Studio Reklamy